Adult stem cells, scaffolds for in vivo and in vitro myocardial tissue engineering by Di Felice, Valentina et al.
© 2010 Firenze University Press 
ht tp://www.fupress .com/ijae
ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY
IJAE 
Vo l .  115,  n .  1/2 :  65 - 69,  2010
Adult stem cells, scaff olds for in vivo and in vitro 
myocardial tissue engineering
Valentina Di Felice1,*, Angela De Luca1, Claudia Serradifalco1, Patrizia Di Marco2, Lucia Verin3, 
Antonella Motta3, Annalisa Guercio2, Giovanni Zummo1
1 Dipartimento BIONEC, Università degli studi di Palermo, Italia. *Corresponding author, Email: vdfelice@inwind.it
2  Istituto Zooprofi lattico Sperimentale della Sicilia, Palermo, Italia.
3  BIOtech Laboratories, Università degli studi di Trento, Italia.
Presented at a meeting in honour of Prof. G. Orlandini, Florence, February 15, 2010
Summary 
The main goal in the last few years in cardiac research has been to isolate cardiac potential stem 
cells from adult myocardium and to demonstrate their differentiation potential. We have previ­
ously demonstrated that c­Kit positive cardiac stem cells are able to organize themselves into a 
tissue­like cell mass. In this 3D mass, they can produce a high concentration of natural extracel­
lular matrix, can create vessels, a capsule and, with the help of an Open­pore Polylactic Acid 
scaffold, many cells can organize an elementary myocardium. 
Drawing from this background, we decided to design and use poly­lactic scaffolds and the 
model of the athymic Nude-Foxn1nu mouse to evaluate the extent of the myogenic vs endothelial 
differentiation in vivo, and to evaluate the presence or the absence of a foreign body reaction.
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Introduction
Cardiac stem or progenitor cells are partially differentiated cells which can be iso­
lated from the adult heart by tissue digestion (Beltrami et al., 2003; Di Felice et al., 
2009; Messina et al., 2004). Convincing evidence has been provided about the pres­
ence of multipotent progenitor cells within the heart and almost all organs, thus sug­
gesting their implication in tissue homeostasis and their possible role as potential tar­
gets for innovative treatments. The injection of mesenchymal or cardiac stem cells in 
vivo into a damaged organ is currently under investigation (Blin et al., 2010; Noort et 
al., 2010). Alternatively, the engraftment of engineered tissue substitutes produced by 
seeding stem cells on biodegradable, biocompatible scaffolds has been proposed as a 
more suitable solution to repair injured tissues (Coutu et al., 2009).
Natural (fi brin, chitosan, collagen, hyaluronic acid) and synthetic (poly­lactic and 
poly­lactic­co­glycolic acid, poly­caprolacton) polymers have been proposed as com­
ponents of scaffolds for tissue engineering. The optimal combination of accurately 
designed scaffolds and stem cells could represent an extraordinary chance to treat sev­
eral degenerative diseases. Cardiac stem cells, in a three­dimensional environment, 
express and assemble phenotype­specifi c proteins in a medium supplemented with 5% 
horse serum, without adding any particular differentiation­stimulating compound (Di 
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Felice et al., 2009). Starting from our previous work, in the present study we decided 
to improve the physical properties of poly­lactic scaffolds, and to understand the steps 
leading cardiac progenitor cells to differentiation both in vitro and in vivo.
Materials and Methods
Cell isolation and purification
We isolated c­Kit positive cells by their proliferative potential, as previously 
described (Di Felice et al., 2009).
Cell seeding in 3D cultures
Cells were seeded as previously described (Di Felice et al., 2009) into the Open­
pore Polylactic Acid (OPLA) scaffold (BD Biosciences) and into the customized 
Poly(d,l)Lactic Acid [P(d,l)LA] composite scaffolds: L150609N, L150609T, L150609U 
(synthesized with a porosity agent less than 224 µm), L070709A (synthesized with a 
porosity agent less than 150 µm). 7 days after seeding, 3D­cultures were injected into 
athymic Nude­Foxn1nu mice.
Flow cytometry analysis
Cells were detached from flasks, counted, and placed into FACS tubes (200,000 
cells/sample). Cells were washed in PBS once and fixed with 4% paraformaldehyde 
in PBS and analyzed as previously described (Di Felice et al., 2009).
Scaffold microfabrication
The porous, three­dimensional P(d,l)LA scaffolds were prepared using a solvent 
cast particulate leaching technique. The polymer was first dissolved in (70:30 v/v) 
dichloromethane/dimethylformamide solvent and then poured into a glass Petri dish 
containing a sufficient amount of NaCl salt. The suspension was then dried under 
hood overnight and washed into water for three days in order to eliminate the resid­
ual solvent and the salt. The sponges obtained were frozen at ­20°C and then lyophi­
lized for 2 days.
Scaffold treatment before cell seeding
Before cell seeding, scaffolds were sterilized with 96% ethanol for 1 h. Thereafter, 
scaffolds were equilibrated with M­199 medium supplemented with 20% FBS, and air 
dried.
Microinjection of scaffolds in the dorsal subcutaneous region of athymic Nude-Foxn1nu mice
Three­dimensional cultures with 100,000 cells/scaffold for each type of scaffold 
have been injected in the dorsal subcutaneous region of athymic Nude-Foxn1nu mice 
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(Harlan laboratories), one scaffold per mouse. Scaffolds maintained in culture for 21 
days and subcutaneous scaffolds from athymic Nude-Foxn1nu mice were fixed in 4% 
formalin for 24h and dehydrated with ethanol 30, 50, 70, 95, 100% v/v. After dehy­
dration, tissue pieces were put into xylol for 1h and embedded into paraffin. Paraffin­
embedded tissue samples were cut into 5 µm sections and stained with haematoxy­
lin/eosin.
Results
Cardiac stem cells isolation and characterization
We isolated immature cells from mature female rats using a differential adhesion 
method as previously described (Di Felice et al., 2009). We improved our protocol, 
and two weeks after tissue digestion 96.7 ± 2.3 % (mean ± standard deviation) of the 
isolated cells were positive for the stem cell marker c­Kit (Figure 1). These cells were 
identified as cardiac stem cells (Di Felice et al., 2009).
Microinjection of cell-embedded P(d,l)LA scaffolds in athymic Nude-Foxn1nu mice
To investigate the survival and morpho­functional potential of the cardiac progeni­
tor cells in vivo, three­dimensional cell embedded P(d,l)LA scaffolds were injected in the 
dorsal subcutaneous region of athymic Nude-Foxn1nu mice. Immature cardiac stem cells 
embedded in Collagen I, cultured in P(d,l)LA scaffolds and left in culture for 21 days 
with 20% FBS as controls, showed a heavy myogenic differentiation, as shown by ema­
toxylin/eosin staining (Figure 2A,B). In these samples myofibrils and vessels were vis­
ible (Figure 2A, B). Cells differentiated also in the customized P(d,l)LA scaffolds. 
Cardiac stem cells injected in the subcutaneous region inside the scaffolds 
behaved differently from the in vitro counterpart. Around the five scaffolds there was 
a capsule and inside the scaffolds there were a few activated macrophages. OPLA 
scaffold induced a heavier and more defined capsule (Figure 2C, E). Customized 
P(d,l)LA scaffolds induced a thinner capsule (Figure 2D). Inside the mass, cardiac 
progenitor cells created vessels which formed anastomosis with the host ones (Fig­
ure 2F). Where nutrients did not arrived, there were areas of necrosis. Air bubbles 
inside the scaffold derived from the scaffold embedding procedure before injection. 
Residues of the scaffold structure were not identified.
Discussion
The complete myocardial differentiation of cardiac stem cells is difficult to 
achieve, both in vitro and in vivo. Here we demonstrated that also maintaining cells 
in a three­dimensional culture inside a poly­lactic scaffold for 21 days, c­Kit positive 
cardiac stem cells may differentiate into pre­cardiomyocytes (large cells enriched in 
myofibrillary proteins).
The main difficulty in using stem cells in vivo is to induce and drive the desired 
differentiation. As already described, a few cardiac progenitor cells, embedded in 
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matrigel and inserted in the dorsal subcutaneous region of SCID mice may differen­
tiate into cardiomyocytes (Messina et al., 2004). We have decided to use this in vivo 
model to better understand if the c­Kit positive cardiac stem cells can differentiate, if 
they can create an organized myocardial tissue, if they can create vessels and above 
all if these cells cultured inside a P(d,l)LA scaffold within collagen may induce a for­
eign body reaction.
Our preliminary results demonstrate that, even if in culture for the same period of 
time almost all c­Kit positive cardiac stem cells differentiate into pre­cardiomyocytes, 
in vivo we do not obtain the same extent of differentiation. By analysing the hema­
toxylin/eosin stained paraffin sections, we can identify some pre­cardiomyocytes, 
many neo­formed vessels, sometimes a capsule and a few macrophages. The presence 
of a capsule, vessels and macrophages may be considered as a foreign body reaction 
(Anderson et al., 2008).
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Figures
Figure 2 – Hematoxylin/eosyn stained paraffin sections of in vitro and in vivo three-dimensional cultures of 
cardiac stem cells into P(d,l)LA scaffolds. Almost all cardiac stem cells differentiated in vitro after 21 days in 
culture, without any differentiation agent (A-B). The same three-dimensional culture, injected in the dorsal 
subcutaneous region of athymic Nude-Foxn1nu mice, did not show the same differentiation as the in vitro 
counterpart, after 21 days (C-F). In vivo implanted cells created a capsule (C-E), many vessels (F) and a few 
pre-cardiomyocytes (C). The presence of the capsule and macrophages may represent signs of a foreign 
body reaction. 
Figure 1 – Phenotyping of isolated cardiac stem cells. Percentage of cells expressing c-Kit by flow cytometry 
after a single differential adhesion selection, two weeks from tissue digestion. On the right an image of CSCs 
in culture. 
